Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Schering AG to commence phase I clinical study with Oncolym

June 27, 2000

Promycin clinical studies put on hold

June 27, 2000

Marimastat does not meet primary or secondary endpoints in brain cancer trial

June 26, 2000

Potent tricyclic protein farnesyltransferase inhibitors described by Schering-Plough

June 26, 2000

Collaboration to develop CpG DNA-based cancer products

June 26, 2000

Mechanism of apoptosis induction elucidated for NIK-333

June 23, 2000

Daiichi commences development of new anticancer compound

June 23, 2000

New research strengthens link between COX-2 and angiogenesis/tumor growth

June 23, 2000

New guanidino distamycin analogue selected by Pharmacia for clinical development

June 22, 2000

Halimide: a new cytotoxic alkaloid discovered at the University of California

June 22, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...